Ellis Christopher

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 49% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ellis Christopher's trades of Barinthus Biotherapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-26 2022-08-25
S Sale
62,972 +21.2%
238.57
US$4,085,737 		62,972 +21.2% 238.57 US$4,085,737
2022-08-26 2022-08-25
S Sale
2,857 +33.2%
99.06
US$4,281,109 		2,857 +33.2% 99.06 US$4,281,109
2022-08-26 2022-08-24
S Sale
44,508 -23.8%
437.61
US$3,760,339 		44,508 -23.8% 437.61 US$3,760,339
2022-08-19 2022-08-18
S Sale
2,175 -96.7%
4.84
US$10,531 		2,175 -96.7% 4.84 US$10,531
2022-08-19 2022-08-17
S Sale
649 -89.6%
4.77
US$3,093 		649 -89.6% 4.77 US$3,093
2022-08-17 2022-08-16
S Sale
2,200 -96.7%
4.78
US$10,513 		2,200 -96.7% 4.78 US$10,513
2022-08-17 2022-08-15
S Sale
5,350 -98.6%
4.76
US$25,463 		5,350 -98.6% 4.76 US$25,463
2022-07-15 2022-06-28
S Sale
5 -6.2%
6.00
US$30 		5 -6.2% 6.00 US$30